Search This Blog

Saturday, May 18, 2024

Trump demands drug test for Biden ahead of first debate

 Former President Trump said he wants President Biden to be drug-tested before their first debate.

“I’m gonna demand a drug test too, by the way,” Trump said at the Minnesota Republican Party’s Lincoln Reagan Dinner Friday. “I am, no I really am. I don’t want him coming in like the State of the Union, he was high as a kite.”

Trump has previously stated in a radio interview that Biden was “all jacked up” at the beginning of his State of the Union address, as well as “higher than a kite.” 

The former president and Biden rapidly agreed to two presidential debates in June and September on CNN and ABC on Wednesday. Biden and Trump now have just a little over a month before they participate in their first debate.

“They gotta be fair, I think they gotta be fair, and if they’re not, you know, you have to deal with it. Right? You have to deal with it,” Trump said at the dinner.

Rep. Greg Murphy (R-N.C.) suggested Thursday that Biden “must’ve been jacked up” when he gave the State of the Union address in March.

“I was in the State of the Union address and Joe Biden must have been jacked up on something that day. I absolutely believe that from a medical viewpoint and actually have a little bit of good knowledge that happened,” Murphy said. “He can’t stand, and he can’t stand under the lights for that long, and I don’t think he can keep a concept in his brain that long.”

The Hill has reached out to the Biden campaign.

https://thehill.com/homenews/campaign/4672061-donald-trump-demands-drug-test-for-joe-biden-ahead-debate/

Boston Scientific has positive modular CRM data

 Boston Scientific (NYSE: BSX)

 today shared data supporting the use of its modular cardiac rhythm management (mCRM) technology.

Marlborough, Massachusetts-based Boston Scientific presented data in an abstract at Heart Rhythm Society in Boston today.

The mCRM system features a novel leadless pacemaker (LP) with wireless communication to a subcutaneous implantable cardioverter defibrillator (S-ICD). This combination delivers anti-tachycardia pacing (ATP) and bradycardia pacing to patients while avoiding transvenous lead complications.

Boston Scientific’s mCRM offering utilizes the Emblem MRI S-ICD system and the Empower modular pacing system (MPS). The company previously touted it as the first leadless pacemaker capable of delivering both bradycardia pacing support and ATP. It kicked off the MODULAR-ATP study evaluating the technology in late 2021.

The multi-center, international trial intends to enroll up to 300 patients at risk of sudden cardiac death (SCD). It evaluates LP safety and mCRM system efficacy with endpoints reported out to six months.

For safety, the trial has a primary endpoint of freedom from major LP-related complications, according to the abstract. Efficacy endpoints evaluated the wireless device communication success between the LP and S-ICD and the LP fixation mechanism. This is measured by low and stable pacing capture thresholds (PCTs).

Boston Scientific reported a major complication-free rate of 97.5%, exceeding the 86% performance criterion. Wireless communication success came in at 98.8% of the patients, exceeding the goal of 88%. The company reported that 97.4% of patients had PCTs at or below the study’s benchmark at six months, topping the 80% performance criterion. Boston Scientific said eight (4.9%) deaths occurred, but none registered an arrhythmic or procedure-related cause.

MODULAR-ATP continues to follow patients out to two years.

https://www.massdevice.com/boston-scientific-positive-mcrm-data/

HCA among beneficiaries of latest U.S. health hack: Jefferies

 Jefferies argued this week that hospital operators such as HCA Healthcare (NYSE:HCA), Tenet Healthcare (NYSE:THC), and Community Health.would be aided. 

"Based on disclosures from Ascension & our local channel checks, the impact on healthcare delivery includes the cancellation/delay of elective procedures & substantial delays in non-emergency care, with several hospitals diverting emergency cases elsewhere," Jefferies analyst Brian Tanquilut wrote.

https://seekingalpha.com/news/4108107-hca-among-beneficiaries-latest-healthcare-hack-jefferies

Oil Tanker Struck By Missile Off Yemen Coast

 As Ukrainian drones relentlessly target Russia's energy complex, tensions in the Middle East are once again rising. Early Saturday, Agence France-Presse reported that a crude oil tanker was hit by a missile off the coast of Yemen. These mounting geopolitical risks underscore the possible need for a higher risk premium on Brent crude prices.

Maritime security firm Ambrey told AFP News that the oil tanker was near the Bab el-Mandeb strait and about ten nautical miles southwest of the city of Mokha at the time of the incident. 

'Ex-NIH Director Confirms 'No Science' Behind 6-Foot Distancing Rules'

 Newly released testimony from former NIH Director Dr. Francis Collins confirms that Anthony Fauci and Deborah Birx did not base the pandemic-era six-foot social distancing rule on science, and instead were making things up as they went along.

On Thursday, Rep. Brad Wenstrup (R-OH), chairman of the Select Subcommittee on the Coronavirus Pandemic, released a transcript from Collins' January closed-door interview, in which he's asked about a range of issues - including the lab-leak theory and the six-foot social distancing rule.

"We asked Dr. Fauci where the six feet came from and he said it kind of just appeared, is the quote," the majority counsel on the committee told Dr. Collins, per the transcript. "Do you recall science or evidence that supported the six-feet distance?"

"I do not," Collins replied.

Counsel then asked, "Is that I do not recall or I do not see any evidence supporting six feet?"

To which Collins replied "I did not see evidence, but I’m not sure I would have been shown evidence at that point."

"Since then, it has been an awfully large topic. Have you seen any evidence since then supporting six feet?" Counsel replied.

"No," said Collins.

As the Epoch Times notes further, the remarks by Dr. Collins offer further indication that officials issuing guidelines at the height of the pandemic were, at least to some extent, making decisions that were not explicitly supported by scientific data.

Various officials involved in crafting the U.S. pandemic response, including Dr. Fauci, have said that they were making good-faith decisions based on the available data at the time and that once new information emerged, they adjusted their recommendations accordingly.

Social Distancing In Focus

As the COVID-19 outbreak spread in 2020, the Centers for Disease Control and Prevention (CDC) issued guidance describing social distancing to include staying away from congregant settings, avoiding mass gatherings, and maintaining a distance of at least six feet from others when possible.

The CDC’s latest guidance on respiratory virus infection prevention (updated on April 4, 2024) includes a section on physical distancing. It indicates that putting physical distance between oneself and others can help lower the risk of spreading a respiratory virus.

There is no single number that defines a ’safe' distance, since spread of viruses can depend on many factors,” the guidance states, which comports with studies such as one from 2021 that concluded that the one-size-fits-all six-foot physical distancing rule is invalid.

However, the CDC’s latest guidance for healthcare settings, updated on March 18, 2024, makes several references to six feet. For instance, it recommends that in dental facilities with open floor plans, one strategy to prevent the spread of COVID-19 is to ensure “at lest 6 feet of space between patient chairs.” It also defines “close contact” between individuals as “being within 6 feet for a cumulative total of 15 minutes or more over a 24-hour period with someone with SARS-CoV-2 infection.”

The Epoch Times has reached out to the CDC with a request for comment on Dr. Collins’s remarks and for clarification on what scientific basis the agency incorporated the six-foot figure into its COVID-19 prevention guidance.

In March, the CDC also updated its guidance for people who test positive for COVID-19, telling them that they no longer need to isolate for five days.

The updated guidance indicated that the threat from COVID-19 has fallen to become more similar to that of other respiratory viruses, and so rather than providing additional virus-specific guidelines, the CDC was opting for a “unified, practical approach.”

In justifying its shift to the new guidelines, which basically treat COVID-19 like any other respiratory virus, the CDC said that many people with respiratory virus symptoms often don’t know which pathogen is causing their symptoms, so a unified approach is more practical.

Numerous doctors had long urged the CDC to drop the five-day isolation recommendation, though as recently as mid-February, the agency continued to hold off on making the change, citing the need for more consultation.

In the updated guidelines, the CDC gave a nod to the “personal and societal costs of extended isolation,” including limited paid sick time.

A number of experts and studies have warned about the harms of prolonged isolation during the pandemic. For instance, the American Psychological Association said in November 2023 that Americans have suffered “collective trauma” related to the pandemic. The association cited a study suggesting that the heavy-handed response to the COVID-19 outbreak—which, in addition to the social distancing rule, included quarantines, school closures, business shutdowns, and near-universal mandating of masks—had a negative effect on people’s physical and mental health.

Another study that looked at a wide array of research into lockdowns concluded that such measures can be an effective tool in controlling the COVID-19 pandemic but only if “long-term collateral damage is neglected.”

The price tag of lockdowns in terms of public health is high: by using the known connection between health and wealth, we estimate that lockdowns may claim 20 times more life years than they save,” the study’s authors wrote.

The researchers also warned about the widespread censorship of dissenting opinions about the lockdowns, noting that it prevents the scientific community from correcting its mistakes and undermines public trust in science.

*  *  *

J&J-backed startup Rapport files for US IPO

 Biopharmaceutical company Rapport Therapeutics, backed by the venture capital arm of Johnson & Johnson, filed for an initial public offering in the United States on Friday.

Rapport, which develops small molecule medicines for patients suffering from central nervous system disorders, is gearing up for a listing as the IPO market recovers from a slump amid increasing hopes of a soft landing for the economy.

The company said it will be selling shares in the IPO, but did not disclose how many nor the price range.

Rapport's net loss widened to $34.8 million in 2023 from $10.7 million a year earlier.

Initially named Precision Neuroscience NewCo, the company plans to use a portion of the IPO proceeds to advance the clinical development of its lead product candidate, RAP-219, for the treatment of focal epilepsy.

Epilepsy is one of the most common neurological diseases, affecting about 50 million people worldwide, according to the World Health Organization.

About 3 million adults in the United States suffer from epilepsy, with 60% of them or 1.8 million people having focal epilepsy.

The company's investors include biotech investor ARCH Venture, investment manager Cormorant Asset Management, fund manager Fidelity and healthcare venture firm Third Rock Ventures, among others.

Boston, Massachusetts-based Rapport was formed in February 2022 with founding support from Third Rock Ventures and Johnson & Johnson Innovation-JJDC.

Last year, the company raised $150 million in a Series B funding round led by Cormorant. The round also included investments from Goldman Sachs Asset Management among other firms.

Since its inception, Rapport has raised about $250 million in equity capital from life sciences investors.

Rapport plans to list on the Nasdaq under the symbol "RAPP".

https://finance.yahoo.com/news/j-j-backed-startup-rapport-212028470.html

How to Win Friends: Zelensky Says 'It's World’s Fault' That Russia Is Gaining

 In a rare personal visit of Ukrainian President Volodymyr Zelensky to the battlefield, particularly to the war-ravaged country's northeastern Kharkiv oblast, he blamed Russia's rapid advance on "the world" for not sending enough weapons. Ukraine's front lines in the region have been collapsing amid a major new Russian cross-border offensive.

"Brigades are not totally equipped because of the package, which we waited through for eight months," he told ABC News during the visit. He was referencing the delayed $61 billion Ukraine aid package which was recently passed and signed into effect by President Biden.

He was specifically asked by a reporter whether he blames the United States for the military setbacks. That's when he asserted: 

"It’s the world’s fault. They gave the opportunity for Putin to occupy. But now the world can help."

But he still seemed to lash out at Washington in particular, given the short supply of US-made Patriot systems. "All we need are two Patriot systems. Russia will not be able to occupy Kharkiv if we have those," he said.

Weeks ago a Ukrainian outlet quoted Zelensky who has been seeking to ramp up the pressure on his backers in NATO:

"Regarding the number of missiles to Patriots, we really expect a positive result in this regard. Thank God that after we convened the Ukraine-NATO Council, we received an assurance that there will be no delays in the process (of supplying missiles to the Patriot systems - ed.), Volodymyr Zelensky said.

EU foreign policy chief Josep Borrell has also been urging allies to act fast, saying last month: "I don’t have Patriots in Brussels, they are in the capitals, and it is up to them to take decisions."

European countries have been consistently told of late they must 'sacrifice' their anti-air defenses as protection of their own populations isn't as pressing an issue at this point.

So this is what it has come to: first European populations are dubiously told that Putin is eyeing expansion of the war deeper into Europe, and next Western countries are told to make drastic decisions which severely weaken their own national security. 

But in addition to lack of air defenses, air superiority, and enough ammo, Ukraine faces the even more significant problem of manpower. Even while widening conscription laws in order to gain enough fighting-able men, there's still the question of properly training new recruits in a timely enough manner.

https://www.zerohedge.com/geopolitical/zelensky-lashes-out-russian-forces-penetrate-kharkiv-its-worlds-fault